Your browser doesn't support javascript.
loading
A new framework for the documentation and interpretation of oral food challenges in population-based and clinical research.
Grabenhenrich, L B; Reich, A; Bellach, J; Trendelenburg, V; Sprikkelman, A B; Roberts, G; Grimshaw, K E C; Sigurdardottir, S; Kowalski, M L; Papadopoulos, N G; Quirce, S; Dubakiene, R; Niggemann, B; Fernández-Rivas, M; Ballmer-Weber, B; van Ree, R; Schnadt, S; Mills, E N C; Keil, T; Beyer, K.
Affiliation
  • Grabenhenrich LB; Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Reich A; Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Bellach J; Department of Paediatric Pneumology and Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Trendelenburg V; Department of Paediatric Pneumology and Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Sprikkelman AB; Department of Pediatric Pulmonology & Pediatric Allergology, University Medical Center Groningen, Groningen, The Netherlands.
  • Roberts G; Clinical and Experimental Sciences Academic Units, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Grimshaw KE; Clinical and Experimental Sciences Academic Units, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Sigurdardottir S; Department of Nutrition and Dietetics, Southampton Children's Hospital, Southampton, UK.
  • Kowalski ML; Department of Immunology, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
  • Papadopoulos NG; Department of Clinical Immunology and Allergy, University of Lódz, Lódz, Poland.
  • Quirce S; Institute of Human Development, University of Manchester, Manchester, UK.
  • Dubakiene R; Allergy Department, 2nd Paediatric Clinic, University of Athens, Athens, Greece.
  • Niggemann B; Department of Allergy, Hospital La Paz Institute for Health Research, Madrid, Spain.
  • Fernández-Rivas M; Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Ballmer-Weber B; Department of Paediatric Pneumology and Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • van Ree R; Allergy Department, Hospital Clinico San Carlos IdISSC, Madrid, Spain.
  • Schnadt S; Allergy Unit, Department of Dermatology, University Hospital, Zürich, Switzerland.
  • Mills EN; Departments of Experimental Immunology and of Otorhinolaryngology, Academic Medical Center, Amsterdam, The Netherlands.
  • Keil T; German Allergy and Asthma Association, Mönchengladbach, Germany.
  • Beyer K; Institute of Inflammation and Repair, University of Manchester, Manchester, UK.
Allergy ; 72(3): 453-461, 2017 Mar.
Article in En | MEDLINE | ID: mdl-27670637
ABSTRACT

BACKGROUND:

The conduct of oral food challenges as the preferred diagnostic standard for food allergy (FA) was harmonized over the last years. However, documentation and interpretation of challenge results, particularly in research settings, are not sufficiently standardized to allow valid comparisons between studies. Our aim was to develop a diagnostic toolbox to capture and report clinical observations in double-blind placebo-controlled food challenges (DBPCFC).

METHODS:

A group of experienced allergists, paediatricians, dieticians, epidemiologists and data managers developed generic case report forms and standard operating procedures for DBPCFCs and piloted them in three clinical centres. The follow-up of the EuroPrevall/iFAAM birth cohort and other iFAAM work packages applied these methods.

RECOMMENDATIONS:

A set of newly developed questionnaire or interview items capture the history of FA. Together with sensitization status, this forms the basis for the decision to perform a DBPCFC, following a standardized decision algorithm. A generic form including details about severity and timing captures signs and symptoms observed during or after the procedures. In contrast to the commonly used dichotomous outcome FA vs no FA, the allergy status is interpreted in multiple categories to reflect the complexity of clinical decision-making.

CONCLUSION:

The proposed toolbox sets a standard for improved documentation and harmonized interpretation of DBPCFCs. By a detailed documentation and common terminology for communicating outcomes, these tools hope to reduce the influence of subjective judgment of supervising physicians. All forms are publicly available for further evolution and free use in clinical and research settings.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Allergens / Biomedical Research / Clinical Studies as Topic / Food / Food Hypersensitivity Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Allergy Year: 2017 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Allergens / Biomedical Research / Clinical Studies as Topic / Food / Food Hypersensitivity Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Allergy Year: 2017 Document type: Article Affiliation country:
...